557 studies found for:    Open Studies | "Hormones"
Show Display Options
Rank Status Study
21 Recruiting Endocrine Dysfunction and Growth Hormone Deficiency in Children With Optic Nerve Hypoplasia
Conditions: Growth Hormone Deficiency;   Septo-Optic Dysplasia;   Hypopituitarism
Intervention: Drug: Nutropin AQ
22 Recruiting Effectiveness and Safety of Firmagon® in Androgen Ablative Therapy of Advanced Hormone-dependent Prostate Carcinoma in Argentina
Condition: Advanced Hormone Dependent Prostate Cancer
Intervention: Drug: Firmagon® (degarelix)
23 Recruiting Safety and Efficacy Phase 2 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children
Condition: Pediatric Growth Hormone Deficiency
Interventions: Drug: MOD-4023;   Drug: Somatropin
24 Unknown  Study of Weekly ALTU-238 Compared With Daily Nutropin AQ in Prepubertal Children With Growth Hormone Deficiency
Condition: Growth Hormone Deficiency
Intervention: Drug: Somatropin
25 Recruiting A Prospective Non-Interventional Study Protocol With Primary Data Collection - Assessment Of The Long Term Treatment Outcomes Of Genotropin Treatment In Growth Hormone Deficiency (GHD) Patients
Condition: Growth Hormone Deficiency
Intervention: Other: Non Interventional Study
26 Recruiting Long-term Safety and Effectiveness of Growth Hormone With GHD, TS, CRF, SGA and ISS in Children
Conditions: Growth Hormone Deficiency;   Turner Syndrome;   Chronic Renal Failure;   Small for Gestational Age;   Idiopathic Short Stature
Intervention:
27 Recruiting A Phase 3, Multicenter Study Designed To Evaluate The Efficacy And Safety Of A Long Acting Hgh Product (Mod-4023) In Adult Subjects With Growth Hormone Deficiency
Condition: Adult Growth Hormone Deficiency
Interventions: Drug: MOD-4023;   Other: Placebo
28 Recruiting CO11109: A Phase 1b Study of TAK-700 in Postmenopausal Women With Hormone-receptor Positive Metastatic Breast Cancer
Condition: Post Menopausal, Hormone Receptor Positive Breast Cancer
Intervention: Drug: TAK700
29 Recruiting A PK Study of 3 Dosages of Tolvaptan in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)
Condition: Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)
Intervention: Drug: tolvaptan
30 Recruiting DETECT IV - A Multicenter Single Arm Phase II Study to Investigate Clinical Efficacy of Everolimus in Combination With Endocrine Therapy in Postmenopausal Patients With Hormone-receptor+ve, HER2-ve MBC and Persisting HER2-ve CTCs
Conditions: HER2-negative Und Hormone-receptor Positive Metastatic Breast Cancer;   HER2-negative Circulating Tumor Cells;   Postmenopausal Female Patients
Intervention: Drug: Everolimus in combination with standard endocrine therapy
31 Recruiting A Global Study to Compare the Effects of Fulvestrant and Arimidex in a Subset of Patients With Breast Cancer.
Condition: Hormone Receptor Positive Breast Cancer
Interventions: Drug: faslodex 500mg;   Drug: arimidex 1mg;   Drug: faslodex dummy;   Drug: arimidex dummy
32 Recruiting Pegvisomant With Glucagon Test to Assess for Adult Growth Hormone Deficiency
Condition: Adults Growth Hormone Deficiency.
Interventions: Drug: Pegvisomant;   Drug: Regular insulin
33 Recruiting Study of Weekly Cabazitaxel for Advanced Prostate Cancer
Condition: Hormone Refractory Prostate Cancer
Intervention: Drug: Cabazitaxel 10 mg/m2
34 Recruiting Analysis of Tumor Tissue and Circulating Genetic Material in the Blood to Obtain Further Insight in the Effectiveness of Everolimus When Combined With Exemestane
Conditions: Hormone Receptor Positive Malignant Neoplasm of Breast;   Metastatic Breast Cancer
Intervention: Drug: Everolimus plus Exemestane
35 Recruiting GH and Cardiovascular Risk Factors
Conditions: Growth Hormone Deficiency;   Cardiovascular Diseases;   Metabolic Syndrome;   Cognition;   Physical Activity
Intervention: Drug: Change in daily dosage of Growth Hormone
36 Unknown  Clinical Study Investigating the Effect of Sodium Nitroprusside Infusion on Thyroidal Function
Conditions: Nitroprusside;   Thyroid Hormones
Interventions: Drug: sodium nitroprusside;   Drug: placebo
37 Recruiting Orteronel in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
Conditions: Adenocarcinoma of the Prostate;   Hormone-resistant Prostate Cancer;   Recurrent Prostate Cancer;   Stage IV Prostate Cancer
Interventions: Drug: orteronel;   Other: laboratory biomarker analysis
38 Recruiting Abiraterone Acetate in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
Conditions: Adenocarcinoma of the Prostate;   Hormone-resistant Prostate Cancer;   Recurrent Prostate Cancer;   Stage IV Prostate Cancer
Interventions: Drug: abiraterone acetate;   Drug: prednisone;   Other: laboratory biomarker analysis;   Other: pharmacological study
39 Recruiting Enzalutamide and Mifepristone in Treating Patients With Metastatic Hormone Resistant Prostate Cancer
Conditions: Hormone-resistant Prostate Cancer;   Recurrent Prostate Cancer;   Stage IV Prostate Cancer
Interventions: Drug: enzalutamide;   Drug: mifepristone;   Other: laboratory biomarker analysis;   Other: pharmacological study
40 Recruiting Alisertib, Abiraterone Acetate and Prednisone in Treating Patients With Hormone-Resistant Prostate Cancer
Conditions: Adenocarcinoma of the Prostate;   Hormone-resistant Prostate Cancer;   Recurrent Prostate Cancer;   Stage IV Prostate Cancer
Interventions: Drug: Alisertib;   Drug: Abiraterone acetate;   Drug: Prednisone

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years